JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moran, J. F.
Right arrow Articles by Sourkes, T. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moran, J. F.
Right arrow Articles by Sourkes, T. L.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*L-TYROSINE
*METHYLDOPA
Journal of Pharmacology And Experimental Therapeutics, Vol. 148, Issue 2, 252-261, 1965
Copyright © 1965 by American Society for Pharmacology and Experimental Therapeutics


MULTIPLE INHIBITORY EFFECTS OF agr-METHYLAMIND ACIDS ON THE METABOLISM OF C14-LABELED TYROSENE, DOPA AND agr-METHYLDOPA

J. F. Moran 1 and T. L. Sourkes 1

1 Allan Memorial Institute, McGill University, Montreal, Canada

A series of "decarboxylase inhibitors" including agr-methyldopa, agr-methyl- m-tyrosine and agr-hydrazino-agr-methyl-3, 4-dihydroxyphenylpropionic acid have been examined for their effects on formation of respiratory C14 O2 from intraperitoneally administered C14-labeled d- and l-tyrosine, d -and dl-dopa, and l-agr-methyldopa. Substantial inhibition of C14 O2 expiration after injection of both carboxyl-and beta labeled tyrosine has been observed in animals receiving agr-methyldopa, agr-methyl-m-tyrosine and the hydrazino analogue of a-methyldopa. The results establish the fact that the a-methylamino acids inhibit enzymes on the main pathway of degradation of tyrosine; their inhibitory action cannot be explained simply on the basis of their well-known antidecarboxylase properties. By comparing the effects of the inhibitors on carboxyl-labeled d-and 1-tyrosine it has been shown that the hydrazino analogue of agr-methyl dopa inhibits l-tyrosine-agr-ketoglutarate transaminase; agr-methyldopa and agr-methyl-m-tyrosine inhibit d-amino acid oxidase and, perhaps, also the transaminase or p-hydroxyphenylpyruvate oxidase (or both).

Inhibition of d-amino acid oxidase by agr-methyldopa, agr-methyl-m-tyrosine and agr-meth-ylmethionine was also observed in experiments with d-and dl-dopa labeled in the carboxyl group. However, the hydrazino compound inhibited the two forms of dopa to the same extent; this result has been discussed in relation to the metabolic fate of 3, 4-dihydroxyphenylpyruvic acid, the presumed first intermediate in the catabolism of d-dopa.

agr-Methyldopa, agr-methyl-m-tyrosine, agr-hydrazino-agr-methyl-3, 4-dihydroxyphenyipropionic acid, agr-methyl-5-hydroxytryptophan, and 5-(3-hydroxycinnamoyl) salicylic acid are effective in inhibiting C14 O2 formation from carboxyllabeled dl-dopa and lagr-methyldopa, thus confirming their "antidecarboxylase" action. However, in experiments utilizing carboxyl-labeled l-tyrosine, agr-methyl-5-hydroxytryptophan and the salicylic acid derivative did not inhibit the formation of respiratory C14O2. It has thus been shown that by the judicious choice of substrate and its labeling in this type of experiment, the specificity of action of the "antidecarboxylases" can be determined in vivo and their other sites of action elucidated.

Accepted on January 12, 1965







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1965 by the American Society for Pharmacology and Experimental Therapeutics.